Treating bladder bacteria in pregnancy to prevent infections
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if a common antibiotic can safely treat bacteria in the urine of pregnant women who have no symptoms, to see if it prevents later infections. It focuses on women in low- and middle-income countries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 20 weeks pregnant.
- You are at least 18 years old (or the local legal adult age).
- You have no symptoms of a urinary tract infection (like burning or urgency).
- You have not taken any antibiotics in the last 14 days.
- You do not have an allergy to nitrofurantoin (a common antibiotic).
- You are not currently taking a magnesium-containing antacid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
This study compares two common antibiotics, nitrofurantoin and fosfomycin, to see which works better for treating bladder infections (cystitis) in women. If you have a bladder infection, this trial will help find the best treatment for you.
This trial tests a therapy (called GAG therapy) to prevent repeat urinary tract infections (UTIs) in adult women. It compares how similar the results are to a well-known antibiotic standard (nitrofurantoin) to see if it works reliably.
This trial compares a new treatment approach—high-dose antibiotics combined with methenamine hippurate—against standard care for women with chronic urinary tract infections (UTIs). It aims to find if the combination works better at relieving persistent symptoms like pain and frequent urination.
This trial tests an investigational tablet called Fluorothiazinone for women with chronic bladder infections (cystitis) that keep coming back. It aims to see if the drug is safe and helps relieve symptoms like pain and frequent urination.
This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.
Hear when a new Preterm Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.